Norges Bank Quidel Ortho Corp Transaction History

Norges Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$32.9 - $47.0 $20.2 Million - $28.8 Million	612,555 New	612,555 $20.3 Million
Q4 2023 Feb 09, 2024	BUY	$58.16 - $75.44 $33.1 Million - $43 Million	569,437 New	569,437 $42 Million
Q3 2023 Nov 13, 2024	BUY	$70.9 - $88.63 $43.6 Million - $54.5 Million	615,324 New	615,324 $44.9 Million
Q3 2023 Nov 13, 2023	SELL	$70.9 - $88.63 $37.4 Million - $46.7 Million	-527,172 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$81.09 - $94.16 $1.72 Million - $2 Million	-21,233 Reduced 3.47%	591,322 $49 Million
Q2 2023 Aug 14, 2023	SELL	$81.09 - $94.16 $41.2 Million - $47.9 Million	-508,352 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$82.98 - $91.46 $45.2 Million - $49.9 Million	545,052 New	545,052 $48.6 Million
Q4 2022 Feb 14, 2023	BUY	$66.93 - $97.5 $35 Million - $50.9 Million	522,346 New	522,346 $44.7 Million
Q3 2022 Nov 13, 2023	BUY	$69.86 - $107.63 $36.8 Million - $56.7 Million	527,172 New	527,172 $37.7 Million
Q2 2022 Aug 14, 2023	BUY	$89.06 - $117.64 $45.3 Million - $59.8 Million	508,352 New	508,352 $49.4 Million

293

67.9M

337K

134K

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.69B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.